Pramod Thomas is a senior correspondent with Asian Media Group since 2020, bringing 19 years of journalism experience across business, politics, sports, communities, and international relations. His career spans both traditional and digital media platforms, with eight years specifically focused on digital journalism. This blend of experience positions him well to navigate the evolving media landscape and deliver content across various formats. He has worked with national and international media organisations, giving him a broad perspective on global news trends and reporting standards.
ONLINE fashion retailer Asos has announced a change in the criteria for its annual executive bonus scheme, no longer requiring leaders to meet diversity targets to qualify for incentives, reported The Telegraph.
The move is seen as a sign of shifting from the environmental, social, and governance (ESG) movement, which is witnessing a decreased emphasis on diversity and increased focus on profitability.
Under the revamped bonus scheme, executives will now primarily be evaluated based on the company's profits, with additional considerations given to improvements in Asos's share price and profit margins.
This marks a departure from the previous bonus structure, where executives were required to meet diversity targets, including increasing female and ethnic minority representation in leadership roles, the report added.
The latest move is seen as a strategy to prioritise the company's return to profitability.
Chief executive José Antonio Ramos Calamonte has recently emphasised that the upcoming year will focus on taking essential measures to revive Asos's growth.
The decision aligns with a broader trend among firms, as evidenced by other notable companies, including Unilever, Shell, and BP, refocusing on profits and recalibrating their ESG strategies in response to investor pressure.
Unilever, known for its ethical stance, abandoned its efforts to imbue all brands with a social purpose, while oil majors Shell and BP renewed their emphasis on traditional energy sources over renewables.
Asos justified its decision by emphasising the need for a turnaround in profits, stating that the management's focus for the upcoming year will be on delivering profitability.
The company's commitment to diversity, however, remains intact, as it plans to incorporate a diversity measure in its longer-term incentive scheme.
Under the plan, executives may see fewer shares vesting if insufficient progress is made on diversity over the next three years.
The move comes at a critical juncture for Asos, which is grappling with financial challenges, including a substantial loss of nearly £300 million in the last fiscal year and a 10 per cent decline in sales.
The company has been exploring strategies to enhance its financial position, including the potential sale of Topshop, a brand it acquired in 2021, to US retailer Authentic Brands.
Meanwhile, Asos said that it plans to achieve 50 per cent female and 15 per cent ethnic minority representation at every leadership level by 2030.
Veterinary practices ordered to publish price lists and disclose corporate ownership under new CMA proposals.
Pet healthcare costs have risen at nearly twice the rate of inflation, investigation finds.
CVS Group shares surge 18 per cent as market welcomes lack of direct price controls on medicines.
Watchdog pushes for price transparency
Britain’s competition watchdog has provisionally ordered veterinary practices to publish price lists and disclose corporate ownership, aiming to give pet owners greater transparency in a sector where costs have risen at nearly twice the rate of inflation.
The Competition and Markets Authority (CMA) said on Wednesday (15) that pet owners are often unaware of prices or not given estimates for treatments that can run into thousands of pounds.
Under the proposed measures, vet businesses must publish prices for common procedures and make clear which practices are independent and which belong to large corporate chains. The watchdog also plans to cap prescription fees and ban bonuses linked to specific treatments.
“We believe that the measures we are proposing would be beneficial to the sector as a whole, including vets and vet nurses,” the CMA stated in its provisional decision report. “Providing better information for pet owners will increase their confidence in vet businesses and the profession.”
Industry reactions
The announcement triggered immediate market reactions. Bloomberg reported Shares of CVS Group, a British veterinary services provider, rose as much as 18 per cent in early London trading before paring gains, whilst Pets at Home traded up to 4.9 per cent higher. Both companies had underperformed since the CMA launched its investigation.
“While the tone of the CMA’s report is sharp, we see few surprises versus our expectations,” said Jefferies analyst Andrew Wade to Bloomberg. “The lack of pricing controls on services notably medicines must be viewed as a positive.”
The veterinary profession offered cautious support for the reforms. Dr Rob Williams, president of the British Veterinary Association, said: “At first glance, there’s lots of positives in the CMA’s provisional decision that both vets and pet owners will welcome, including greater transparency of pricing and practice ownership."
However, animal welfare charities warned of the consequences when pet owners delay treatment due to cost concerns. Caroline Allen, the RSPCA’s Chief Veterinary Officer, told BBC “Our frontline officers sadly see first-hand the consequences when people delay or avoid seeking professional help, or even attempt to treat conditions themselves."
The proposed remedies package also includes requirements for vet businesses to improve complaint processes and conduct regular customer satisfaction surveys comparing large groups with independent practices. Additionally, practices would find it easier to terminate out-of-hours contracts with third-party providers if better alternatives exist.
The CMA emphasised that vet businesses failing to comply, or those pressuring veterinarians to act in certain ways or sell specific treatments, could be in breach of the Order.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.